Results 271 to 280 of about 2,503,709 (341)

The clinical perspective on malignancies in renal transplanted patients

, 2016
Vivan Hellström
openalex   +1 more source

Recanalization of Thrombosed Atrial Flow Regulator in Failing Fontan: A Bridge to Transplant

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We report the case of a 10‐year‐old boy (41 kg, 133 cm) with hypoplastic left heart syndrome (mitral and aortic atresia), who underwent staged palliation: Norwood‐Sano at 6 days, Glenn at 7 months, and Fontan completion at 3 years using a 16 mm non‐fenestrated extracardiac Gore‐Tex conduit.
Raymond N. Haddad, Estibaliz Valdeolmillos, Emre Belli, Sébastien Hascoët   +3 more
wiley   +1 more source

Understanding "Null Allele" in Renal Transplantation. [PDF]

Transplant Direct
Sulaiman S, Hafeeq B, Suhail Ediyangara Palliparamb M, Krishnakumar A, Khan MS, Aziz F.   +5 more
europepmc   +1 more source

Gene Polymorphisms Play an Important Role in the Drug Interaction Between Posaconazole and Tacrolimus in Renal Transplant Patients

Nan Hu, Mengmeng Guan, Bin Gu, Xuping Yang, Qing Qian, Di Zhao, Hui Xue, J. Jiang   +7 more
openalex   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis

Clinical Pharmacology &Therapeutics, EarlyView.
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis   +5 more
wiley   +1 more source

Renal transplantation in Alport syndrome. [PDF]

Kidney Res Clin Pract
Kim S, Kwon SH.
europepmc   +1 more source

A 6-Month, Multicenter, Single-Arm Pilot Study to Evaluate the Efficacy and Safety of Generic Tacrolimus (TacroBell) After Primary Renal Transplantation

, 2009
Sung‐Jae Kim, Kyu Ha Huh, Duck Jong Han, In Sung Moon, S.-J. Kim, Y.-L. Kim, H.C. Kim, S. Lee, Chong Myung Kang, B.-H. Cho, Yu Seun Kim, Y.S. Kim, Y.S. Kim   +12 more
openalex   +2 more sources

Cystatin C‐based eGFR better predicts renal vancomycin clearance than creatinine‐based eGFR in patients with allogeneic stem cell transplantation

Clinical Pharmacology &Therapeutics, EarlyView.
Knowledge of the glomerular filtration rate (GFR) is mandatory when dosing renally eliminated drugs such as vancomycin. In clinical practice, different biomarkers and various equations are used to estimate GFR (eGFR), resulting in varying estimates.
Eva‐Maria A. Wansing, Sebastian G. Wicha, Peter Bannas, Alexander Heitkamp, Adrin Dadkhah, Nicolaus M. Kröger, Isabel Molwitz, Claudia Langebrake   +7 more
wiley   +1 more source

Exposure to mycophenolic acid at standard prescribed doses in renal transplantation recipients and clinical outcomes in the early posttransplantation period. [PDF]

Indian J Urol
Singh S, Panwar R, Naithani P, Kathik NVKN, Sharma N, Gowda N, Kenwar DB, Kumar SPS, Singh S, Pattanaik S, Sharma A.   +10 more
europepmc   +1 more source

Principles of whole organ transplantation [PDF]

, 1984
Iwatsuki, S, Shaw, BW, Starzl, TE
core